C. R. Rossi, M. Foletto, A. Vecchiato, S. Alessio, N. Menin et al., Management of cutaneous melanoma M0: state of the art and trends, European Journal of Cancer, vol.33, issue.14, pp.33-2302, 1997.
DOI : 10.1016/S0959-8049(97)00358-4

R. Dummer and K. Hoek, Human Melanoma: From Transcriptome to Tumor Biology, 2004.

V. Winnepenninckx, V. Lazar, S. Michiels, P. Dessen, M. Stas et al., Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome, JNCI Journal of the National Cancer Institute, vol.98, issue.7, pp.98-472, 2006.
DOI : 10.1093/jnci/djj103

L. Raskin, D. R. Fullen, T. J. Giordano, D. G. Thomas, M. L. Frohm et al., Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis, Journal of Investigative Dermatology, vol.133, issue.11, pp.133-2585, 2013.
DOI : 10.1038/jid.2013.197

K. Dutton?regester and N. K. Hayward, Reviewing the somatic genetics of melanoma: from current to future analytical approaches. Pigment cell & melanoma research, pp.144-154, 2012.

I. Maglogiannis, T. Goudas, A. Billiris, H. Karanikas, I. Valavanis et al., Redesigning EHRs and Clinical Decision Support Systems for the Precision Medicine Era, Proceedings of the 16th International Conference on Engineering Applications of Neural Networks (INNS), EANN '15, p.14, 2015.
DOI : 10.1186/s13059-014-0550-8

H. Li and R. Durbin, Fast and accurate long-read alignment with Burrows???Wheeler transform, Bioinformatics, vol.26, issue.5, 2010.
DOI : 10.1093/bioinformatics/btp698

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828108

A. Mckenna, The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data, Genome Research, vol.20, issue.9, pp.1297-1303, 2010.
DOI : 10.1101/gr.107524.110

K. Cibulskis, Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples, Nature Biotechnology, vol.27, issue.3, pp.31-213, 2013.
DOI : 10.1093/bioinformatics/btr446

E. D. Pilalis and A. A. Chatziioannou, Prioritized functional analysis of biological experiments using resampling and noise control methodologies, 13th IEEE International Conference on BioInformatics and BioEngineering, 2013.
DOI : 10.1109/BIBE.2013.6701558

K. Moutselos, GOrevenge: A Novel Generic Reverse Engineering Method for the Identification of Critical Molecular Players, Through the Use of Ontologies, IEEE Transactions on Biomedical Engineering, vol.58, issue.12, pp.3522-3527, 2011.
DOI : 10.1109/TBME.2011.2164794

K. Moutselos, I. Maglogiannis, and A. Chatziioannou, Integration of High-Volume Molecular and Imaging Data for Composite Biomarker Discovery in the Study of Melanoma, BioMed Research International, vol.40, issue.1, 2014.
DOI : 10.1016/0167-4889(94)90062-0

T. Barrett, D. B. Troup, and S. E. Wilhite, NCBI GEO: archive for functional genomics data sets -10 years on Obstructive nephropathy: towards biomarker discovery and gene therapy, Database issue, pp.1005-1015, 2006.

F. Martin-belmonte and M. Perez-moreno, Epithelial cell polarity, stem cells and cancer, Nature Reviews Cancer, vol.8, pp.23-38, 2012.
DOI : 10.1016/j.devcel.2005.04.011

A. Jögi, M. Vaapil, M. Johansson, and S. Påhlman, Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors, Upsala Journal of Medical Sciences, vol.13, issue.3, pp.217-224, 2012.
DOI : 10.1016/j.ccr.2007.12.005

S. Saladi, Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness, Molecular Cancer, vol.9, issue.1, p.280, 2010.
DOI : 10.1186/1476-4598-9-280

I. R. Hart, M. Birch, and J. F. Marshall, Cell adhesion receptor expression during melanoma progression and metastasis, CANCER AND METASTASIS REVIEW, vol.8, issue.2, pp.115-128, 1991.
DOI : 10.1016/S0014-2964(73)80022-2

L. M. Machesky, Lamellipodia and filopodia in metastasis and invasion, FEBS Letters, vol.271, issue.14, pp.2102-2111, 2008.
DOI : 10.1074/jbc.271.21.12632

T. Kato, K. Kawai, Y. Egami, Y. Kakehi, and N. Araki, Rac1-Dependent Lamellipodial Motility in Prostate Cancer PC-3 Cells Revealed by Optogenetic Control of Rac1 Activity, PLoS ONE, vol.41, issue.5, p.97749, 2014.
DOI : 10.1371/journal.pone.0097749.s005

E. B. Pasquale, Eph receptors and ephrins in cancer: bidirectional signalling and beyond, Nature Reviews Cancer, vol.130, issue.3, pp.165-180, 2010.
DOI : 10.1016/S1476-5586(03)80047-7

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921274

A. J. Ridley, Rho proteins and cancer. Breast cancer research and treatment, pp.13-19, 2004.
DOI : 10.1023/b:brea.0000018423.47497.c6

E. E. Sander and J. G. Collard, Rho-like GTPases, European Journal of Cancer, vol.35, issue.9, pp.1302-1308, 1999.
DOI : 10.1016/S0959-8049(99)00145-8